Related Experiment Video
Updated: Aug 3, 2026

Examining the Dynamics of Cellular Adhesion and Spreading of Epithelial Cells on Fibronectin During Oxidative Stress
Published on: October 13, 2019
Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Abstract:
NIH 3T3 fibroblasts stably transformed with a constitutively active isoform of p21(Ras), H-RasV12 (v-H-Ras or EJ-Ras), produced large amounts of the reactive oxygen species superoxide (.O2-). .O2- production was suppressed by the expression of dominant negative isoforms of Ras or Rac1, as well as by treatment with a farnesyltransferase inhibitor or with diphenylene iodonium, a flavoprotein inhibitor. The mitogenic activity of cells expressing H-RasV12 was inhibited by treatment with the chemical antioxidant N-acetyl-L-cysteine. Mitogen-activated protein kinase (MAPK) activity was decreased and c-Jun N-terminal kinase (JNK) was not activated in H-RasV12-transformed cells. Thus, H-RasV12-induced transformation can lead to the production of .O2- through one or more pathways involving a flavoprotein and Rac1. The implication of a reactive oxygen species, probably .O2-, as a mediator of Ras-induced cell cycle progression independent of MAPK and JNK suggests a possible mechanism for the effects of antioxidants against Ras-induced cellular transformation.
Insights
Constitutively active H-RasV12 transforms cells, increasing reactive oxygen species (ROS) like superoxide. Antioxidants and inhibitors targeting Ras pathways, flavoproteins, and Rac1 suppressed ROS and cell growth, suggesting ROS mediation in Ras-induced transformation.
Area of Science:
- Cell Biology
- Biochemistry
- Oncology
Background:
- Ras proteins are key regulators of cell signaling pathways.
- Aberrant Ras signaling is implicated in various cancers.
- Reactive oxygen species (ROS) play complex roles in cell proliferation and transformation.
Purpose of the Study:
- To investigate the role of reactive oxygen species (ROS) in H-RasV12-induced fibroblast transformation.
- To identify the signaling pathways involved in ROS production downstream of H-RasV12.
- To explore the potential of targeting ROS pathways as a therapeutic strategy against Ras-driven cancers.
Main Methods:
- NIH 3T3 fibroblasts were stably transformed with H-RasV12.
- Superoxide (.O2-) production was measured.
- Dominant-negative Ras and Rac1 isoforms were expressed.
- Cells were treated with farnesyltransferase inhibitor and diphenylene iodonium.
- Mitogenic activity was assessed after N-acetyl-L-cysteine treatment.
- Mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) activities were analyzed.
Main Results:
- H-RasV12-transformed cells exhibited significantly increased superoxide (.O2-) production.
- .O2- production was reduced by dominant-negative Ras/Rac1, farnesyltransferase inhibitor, and diphenylene iodonium.
- Antioxidant treatment (N-acetyl-L-cysteine) inhibited the mitogenic activity of H-RasV12 cells.
- MAPK activity was decreased, and JNK was not activated in H-RasV12-transformed cells.
Conclusions:
- H-RasV12-induced cell transformation is associated with increased ROS production, specifically superoxide (.O2-).
- Rac1 and flavoprotein-dependent pathways are involved in H-RasV12-mediated ROS generation.
- Ras-induced cell cycle progression may be mediated by ROS independently of MAPK and JNK pathways, suggesting a novel therapeutic target for Ras-driven cancers.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades

